Remote Monitoring in Progressive Supranuclear Palsy (PSP)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorMassachusetts General Hospital
About this trial
This is a single-arm, longitudinal, observational study on the use of wearable sensors and digital health technology to measure fall frequency and motor, speech, and cognitive function in patients with PSP over the course of approximately one year. Participants will perform supervised remote assessments monthly and in-person assessments approximately every 6 months.
Eligibility criteria
Qualifiers
Clinical diagnosis of possible or probable PSP phenotype as defined by the 2017 MDS criteria, clinical diagnosis of at least probable PD as defined by the 2015 MDS criteria, or clinical diagnosis of at least probable MSA as defined by the 2022 MDS criteria, or healthy controls.
Male or female, aged 18 to 89 years, inclusive.
Fluent in reading and speaking English.
Capable of providing informed consent based on the investigator's judgment.
Disqualifiers
Any neurological, medical, or psychiatric condition that would preclude participation in study activities based on the investigator's judgment.
A history of frequent falls defined as more than 5 falls/month or requirement of a walker to ambulate safely.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Massachusetts General Hospital
Lead sponsor
Johns Hopkins University
Collaborator
Source ClinicalTrials.gov